erythromycin

erythromycin is a lipid of Polyketides (PK) class. Erythromycin is associated with abnormalities such as Systemic Inflammatory Response Syndrome, Pneumonia, Infection, Pneumococcal Infections and Exanthema. The involved functions are known as Pharmacodynamics, Sterility, Agent, Drug Kinetics and Adjudication. Erythromycin often locates in Blood, peritoneal, Extracellular, Ribosomes and apicoplast. The associated genes with erythromycin are P4HTM gene, SLC33A1 gene, FAM3B gene, Operon and Homologous Gene. The related lipids are Hydroxytestosterones, Steroids, Propionate, Mycolic Acids and campesterol. The related experimental models are Mouse Model and Knock-out.

Cross Reference

Introduction

To understand associated biological information of erythromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with erythromycin?

erythromycin is suspected in Pneumonia, Infection, Gonorrhea, Cystic Fibrosis, Respiratory Tract Infections, Influenza and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with erythromycin

MeSH term MeSH ID Detail
Diabetes Mellitus, Experimental D003921 85 associated lipids
Body Weight D001835 333 associated lipids
Edema D004487 152 associated lipids
Esophageal Neoplasms D004938 20 associated lipids
Bone Resorption D001862 7 associated lipids
Arthritis D001168 41 associated lipids
Surgical Wound Infection D013530 7 associated lipids
Abscess D000038 13 associated lipids
Hypotension D007022 41 associated lipids
Acute Kidney Injury D058186 34 associated lipids
Per page 10 20 50 100 | Total 442

PubChem Associated disorders and diseases

What pathways are associated with erythromycin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with erythromycin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with erythromycin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with erythromycin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with erythromycin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with erythromycin?

Mouse Model

Mouse Model are used in the study 'In vitro and in vivo activities of macrolide derivatives against Mycobacterium tuberculosis.' (Falzari K et al., 2005) and Mouse Model are used in the study 'Activity of ABT-773 against Mycobacterium avium complex in the beige mouse model.' (Cynamon MH et al., 2000).

Knock-out

Knock-out are used in the study 'Functional expression and comparative characterization of nine murine cytochromes P450 by fluorescent inhibition screening.' (McLaughlin LA et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with erythromycin

Download all related citations
Per page 10 20 50 100 | Total 13660
Authors Title Published Journal PubMed Link
Odland BA et al. Antimicrobial activity of gatifloxacin (AM-1155, CG5501), and four other fluoroquinolones tested against 2,284 recent clinical strains of Streptococcus pneumoniae from Europe, Latin America, Canada, and the United States. The SENTRY Antimicrobial Surveillance Group (Americas and Europe). 1999 Diagn. Microbiol. Infect. Dis. pmid:10459483
Luna VA et al. A variety of gram-positive bacteria carry mobile mef genes. 1999 J. Antimicrob. Chemother. pmid:10459806
Arpin C et al. Emergence of mefA and mefE genes in beta-haemolytic streptococci and pneumococci in France. 1999 J. Antimicrob. Chemother. pmid:10459823
Ando M et al. A new look at hypersensitivity pneumonitis. 1999 Curr Opin Pulm Med pmid:10461534
Cerbo M and Vecchione R [L-forms and pigment production in "Pseudomonas aeruginosa" (author's transl)]. 1978 May-Jun Ann Sclavo pmid:104666
Manners BT et al. An investigation of antibiotic resistance of Staphylococcus aureus in general practice. 1976 Practitioner pmid:1046672
Di Lorenzo C et al. Effect of sequential erythromycin and octreotide on antroduodenal manometry. 1999 J. Pediatr. Gastroenterol. Nutr. pmid:10467994
Huovinen P Causes, diagnosis and treatment of pharyngitis. 1999 Jun-Jul Compr Ther pmid:10470516
De Azavedo JC et al. Prevalence and mechanisms of macrolide resistance in clinical isolates of group A streptococci from Ontario, Canada. 1999 Antimicrob. Agents Chemother. pmid:10471555
Cross NA et al. Antimicrobial susceptibility testing of Chlamydia trachomatis using a reverse transcriptase PCR-based method. 1999 Antimicrob. Agents Chemother. pmid:10471587
Nawaz MS et al. Biochemical and molecular characterization of erthromycin-resistant avian Staphylococcus spp. isolated from chickens. 1999 Poult. Sci. pmid:10472846
Sofer D et al. 'Subinhibitory' erythromycin represses production of Pseudomonas aeruginosa lectins, autoinducer and virulence factors. 1999 Sep-Oct Chemotherapy pmid:10473921
Mikamo H et al. Adequate macrolide treatment schedules for uterine cervicitis caused by Chlamydia trachomatis. 1999 Sep-Oct Chemotherapy pmid:10473928
Sturm A et al. Prokinetics in patients with gastroparesis: a systematic analysis. 1999 Sep-Oct Digestion pmid:10473966
Syphilis: CDC recommended treatment schedules 1976. 1976 Prim. Care pmid:1047450
Mikasa K et al. [Clinical application of the new action of macrolide preparations to respiratory diseases]. 1999 Nippon Naika Gakkai Zasshi pmid:10475020
Rizzo G et al. [Behavior of Vibrio cholerae strains of the biotype El Tor isolated in Apulia in 1973, in relation to various antibiotics and chemotherapeutics]. 1975 May-Jun Ann Sclavo pmid:1047628
Madinier IM et al. Resistance profile survey of 50 periodontal strains of Actinobacillus actinomyectomcomitans. 1999 J. Periodontol. pmid:10476896
Gabriëls M et al. Densitometric thin layer chromatographic analysis of tretinoin and erythromycin in lotions for topical use in acne treatment. 1999 Eur J Pharm Biopharm pmid:10477329
Howard KB et al. Azithromycin versus erythromycin for community-acquired pneumonia: a cost-minimization analysis. 1999 Am J Health Syst Pharm pmid:10478989
Wilson DJ et al. Comparison of seven antibiotic treatments with no treatment for bacteriological efficacy against bovine mastitis pathogens. 1999 J. Dairy Sci. pmid:10480091
Cizman M et al. Influence of increased macrolide consumption on macrolide resistance of common respiratory pathogens. 1999 Eur. J. Clin. Microbiol. Infect. Dis. pmid:10482034
Sarisuta N et al. Physico-chemical characterization of interactions between erythromycin and various film polymers. 1999 Int J Pharm pmid:10486428
Gómez-Lus R et al. Is there an ecological relationship between rates of antibiotic resistance of species of the genus Streptococcus? The Spanish Surveillance Group for Respiratory Pathogens. 1999 J. Clin. Microbiol. pmid:10488213
Wieckiewicz JA Relationship between resistance to metallic ions and production of beta-lactamase in strains of Staphylococcus epidermidis. 1976 J Hyg Epidemiol Microbiol Immunol pmid:1048968
Kirsten D and Meister W [Present possibilities of antibiotic therapy in chronic non-specific respiratory diseases (author's transl)]. 1976 Z Erkr Atmungsorgane pmid:1049185
Moore PA Dental therapeutic indications for the newer long-acting macrolide antibiotics. 1999 J Am Dent Assoc pmid:10492541
Cash P et al. A proteomic analysis of erythromycin resistance in Streptococcus pneumoniae. 1999 Electrophoresis pmid:10493130
Gibson EM et al. Transfer of plasmid-mediated antibiotic resistance from streptococci to lactobacilli. 1979 J. Bacteriol. pmid:104973
Azuma A and Kudoh S [Diffuse panbronchiolitis: DPB]. 1999 Nippon Rinsho pmid:10497417
Zgoulli S et al. Microencapsulation of erythromycin and clarithromycin using a spray-drying technique. 1999 Sep-Oct J Microencapsul pmid:10499837
Moreno M et al. Clinical management of tacrolimus drug interactions in renal transplant patients. 1999 Transplant. Proc. pmid:10500564
Widdowson CA and Klugman KP Molecular mechanisms of resistance to commonly used non-betalactam drugs in Streptococcus pneumoniae. 1999 Semin Respir Infect pmid:10501313
Rosendal K et al. Staphylococcus aureus strains isolated in Danish hospitals from January 1st, 1966, to December 31st, 1974. 1976 Acta Pathol Microbiol Scand B pmid:1050144
Miossec-Bartoli C et al. The new ketolide HMR3647 accumulates in the azurophil granules of human polymorphonuclear cells. 1999 Antimicrob. Agents Chemother. pmid:10508024
Oster P et al. Patterns of macrolide resistance determinants among community-acquired Streptococcus pneumoniae isolates over a 5-year period of decreased macrolide susceptibility rates. 1999 Antimicrob. Agents Chemother. pmid:10508033
Khan SA et al. Simultaneous detection of erythromycin-resistant methylase genes ermA and ermC from Staphylococcus spp. by multiplex-PCR. 1999 Mol. Cell. Probes pmid:10508560
Ahmad M et al. Disposition kinetics of erythromycin in normal and experimentally-induced febrile rabbits. 1999 Apr-Jun Eur J Drug Metab Pharmacokinet pmid:10510739
McMullin ST et al. Impact of a Web-based clinical information system on cisapride drug interactions and patient safety. 1999 Arch. Intern. Med. pmid:10510994
Kinirons MT et al. Failure of erythromycin breath test to correlate with midazolam clearance as a probe of cytochrome P4503A. 1999 Clin. Pharmacol. Ther. pmid:10511057
Ball SE et al. Population distribution and effects on drug metabolism of a genetic variant in the 5' promoter region of CYP3A4. 1999 Clin. Pharmacol. Ther. pmid:10511065
Chantarotorn S et al. Diffuse panbronchiolitis, the first case reports in Thailand. 1999 J Med Assoc Thai pmid:10511794
Yoshida H and Furuta T [Tissue penetration properties of macrolide antibiotics--comparative tissue distribution of erythromycin-stearate, clarithromycin, roxithromycin and azithromycin in rats]. 1999 Jpn J Antibiot pmid:10516929
De Winter BY et al. Effect of different prokinetic agents and a novel enterokinetic agent on postoperative ileus in rats. 1999 Gut pmid:10517907
Xue Q et al. A multiplasmid approach to preparing large libraries of polyketides. 1999 Proc. Natl. Acad. Sci. U.S.A. pmid:10518520
Sheu BS et al. A three-day course of intravenous omeprazole plus antibiotics for H. pylori-positive bleeding duodenal ulcer. 1999 Jul-Aug Hepatogastroenterology pmid:10521999
Cocito C and Di Giambattista M The in vitro binding of virginiamycin M to bacteria ribosomes and ribosomal subunits. 1978 Mol. Gen. Genet. pmid:105240
Shortridge VD et al. Prevalence of macrolide resistance mechanisms in Streptococcus pneumoniae isolates from a multicenter antibiotic resistance surveillance study conducted in the United States in 1994-1995. 1999 Clin. Infect. Dis. pmid:10524961
Yoh M et al. Effect of subinhibitory concentrations of antimicrobial agents (quinolones and macrolide) on the production of verotoxin by enterohemorrhagic Escherichia coli O157:H7. 1999 Can. J. Microbiol. pmid:10526400
Sato A et al. Effects of organic anions and vinblastine on biliary excretion of erythromycin in rats. 1999 Pharmacology pmid:10529657
Janier M [Syphilis (except congenital syphilis)]. 1999 Aug-Sep Ann Dermatol Venereol pmid:10530355
Schmidtke LM and Carson J Induction, characterisation and pathogenicity in rainbow trout Oncorhynchus mykiss (Walbaum) of Lactococcus garvieae L-forms. 1999 Vet. Microbiol. pmid:10535774
Nicholas KC et al. Periadenitis mucosa necrotica recurrens. 1975 J Oral Surg pmid:1053656
Tobback K et al. Micellar electrokinetic capillary chromatography of macrolide antibiotics. Separation of tylosin, erythromycin and their related substances. 1999 J Chromatogr A pmid:10536850
Maeda K et al. [A case of common variable immunodeficiency that responded to long-term erythromycin chemotherapy]. 1999 Nihon Kokyuki Gakkai Zasshi pmid:10540836
Aoki Y and Kao PN Erythromycin inhibits transcriptional activation of NF-kappaB, but not NFAT, through calcineurin-independent signaling in T cells. 1999 Antimicrob. Agents Chemother. pmid:10543746
Netherwood T et al. Probiotics shown to change bacterial community structure in the avian gastrointestinal tract. 1999 Appl. Environ. Microbiol. pmid:10543832
Jobe DA et al. Detection of borreliacidal antibodies in Lyme borreliosis patient sera containing antimicrobial agents. 1999 Clin. Diagn. Lab. Immunol. pmid:10548588
Zallen RD and Curry JT A study of antibiotic usage in compound mandibular fractures. 1975 J Oral Surg pmid:1055204
Watanabe M et al. Role of CYP3A in bromperidol metabolism in rat in vitro and in vivo. 1999 Xenobiotica pmid:10553724
Erythromycin and gastroparesis? Off-licence use: uncertain efficacy for a poorly defined disorder. 1999 Prescrire Int pmid:10557568
Malonza IM et al. A randomized, double-blind, placebo-controlled trial of single-dose ciprofloxacin versus erythromycin for the treatment of chancroid in Nairobi, Kenya. 1999 J. Infect. Dis. pmid:10558945
Reeves AR et al. Transcriptional organization of the erythromycin biosynthetic gene cluster of Saccharopolyspora erythraea. 1999 J. Bacteriol. pmid:10559177
Denis A et al. Synthesis and antibacterial activity of HMR 3647 a new ketolide highly potent against erythromycin-resistant and susceptible pathogens. 1999 Bioorg. Med. Chem. Lett. pmid:10560728
Bauer JF et al. Role of an isomorphic desolvate in dissolution failures of an erythromycin tablet formulation. 1999 J Pharm Sci pmid:10564073
Morel P et al. Clinical efficacy and safety of a topical combination of retinaldehyde 0.1% with erythromycin 4% in acne vulgaris. 1999 Clin. Exp. Dermatol. pmid:10564319
Matsuoka M et al. Cloning and sequences of inducible and constitutive macrolide resistance genes in Staphylococcus aureus that correspond to an ABC transporter. 1999 FEMS Microbiol. Lett. pmid:10564793
Menezes CM et al. In vitro evaluation of erythromycin in chloroquine resistant brazilian P. falciparum freshly isolates: modulating effect and antimalarial activity evidence. 1999 Jul-Aug Rev. Inst. Med. Trop. Sao Paulo pmid:10564920
Melo-Cristino J and Fernandes ML Streptococcus pyogenes isolated in Portugal: macrolide resistance phenotypes and correlation with T types. Portuguese Surveillance Group for the Study of Respiratory Pathogens. 1999 Microb. Drug Resist. pmid:10566873
Mostaghim D and Millard HD Bacterial endocarditis: a retrospective study. 1975 Oral Surg. Oral Med. Oral Pathol. pmid:1057148
Kondo T et al. Application of liquid chromatography-turbo ion spray tandem mass spectrometry for quantitative analysis of a potent motilin receptor agonist, EM574, and its metabolites in human plasma. 1999 J. Chromatogr. B Biomed. Sci. Appl. pmid:10574195
Clarke AE et al. Interaction of bile with erythromycin Lactobionate in vitro. 1975 Aust N Z J Med pmid:1057910
Peng L and Nimni ME Delivery of erythromycin to subcutaneous tissues in rats by means of a trans-phase delivery system. 1999 J. Pharm. Pharmacol. pmid:10579684
Brown MS et al. Production of 6-deoxy-13-cyclopropyl-erythromycin B by Saccharopolyspora erythraea NRRL 18643. 1999 J. Antibiot. pmid:10580387
Kudo S [Diffuse panbronchiolitis and erythromycin therapy]. 1999 Nippon Naika Gakkai Zasshi pmid:10581765
Klausner MA Astemizole use with erythromycin. 1999 Ann. Allergy Asthma Immunol. pmid:10582723
Zarazaga M et al. In vitro activities of ketolide HMR3647, macrolides, and other antibiotics against Lactobacillus, Leuconostoc, and Pediococcus isolates. 1999 Antimicrob. Agents Chemother. pmid:10582908
McCrea J et al. Concurrent administration of the erythromycin breath test (EBT) and oral midazolam as in vivo probes for CYP3A activity. 1999 J Clin Pharmacol pmid:10586386
Durak H et al. Tc-99m erythromycin lactobionate inhalation scintigraphy in parenchymal lung diseases. 1999 Nucl. Med. Biol. pmid:10587109
Carsenti-Etesse H et al. Gradient plate method to induce Streptococcus pyogenes resistance. 1999 J. Antimicrob. Chemother. pmid:10588303
Marchese A et al. Macrolide resistance mechanisms and expression of phenotypes among Streptococcus pneumoniae circulating in Italy. 1999 J. Antimicrob. Chemother. pmid:10588306
Wilson R et al. Five day moxifloxacin therapy compared with 7 day clarithromycin therapy for the treatment of acute exacerbations of chronic bronchitis. 1999 J. Antimicrob. Chemother. pmid:10588312
Panagea S et al. Should clindamycin be used as treatment of patients with infections caused by erythromycin-resistant staphylococci? 1999 J. Antimicrob. Chemother. pmid:10588329
Varaldo PE et al. Nationwide survey in Italy of treatment of Streptococcus pyogenes pharyngitis in children: influence of macrolide resistance on clinical and microbiological outcomes. Artemis-Italy Study Group. 1999 Clin. Infect. Dis. pmid:10589905
Glass D et al. A placebo-controlled clinical trial to compare a gel containing a combination of isotretinoin (0.05%) and erythromycin (2%) with gels containing isotretinoin (0.05%) or erythromycin (2%) alone in the topical treatment of acne vulgaris. 1999 Dermatology (Basel) pmid:10592405
Debbia EA [Antibiotic resistance: an always present problem]. 1999 Recenti Prog Med pmid:10592734
Brixius B et al. [Ventricular tachycardia after erythromycin administration in a newborn with congenital AV-block]. 1999 Nov-Dec Klin Padiatr pmid:10592929
Damkier P et al. Effect of diclofenac, disulfiram, itraconazole, grapefruit juice and erythromycin on the pharmacokinetics of quinidine. 1999 Br J Clin Pharmacol pmid:10594487
Doumith M et al. Interspecies complementation in Saccharopolyspora erythraea : elucidation of the function of oleP1, oleG1 and oleG2 from the oleandomycin biosynthetic gene cluster of Streptomyces antibioticus and generation of new erythromycin derivatives. 1999 Mol. Microbiol. pmid:10594828
Portillo A et al. Macrolide resistance phenotypes and mechanisms of resistance in Streptococcus pyogenes in La Rioja, Spain. 1999 Int. J. Antimicrob. Agents pmid:10595574
Sugiyama Y et al. Effects of long-term administration of erythromycin on cytokine production in rat alveolar macrophages. 1999 Eur. Respir. J. pmid:10596699
Polk RE et al. Pharmacokinetic interaction between ketoconazole and amprenavir after single doses in healthy men. 1999 Pharmacotherapy pmid:10600086
Esposito S et al. In vitro activity of moxifloxacin compared to other fluoroquinolones against different erythromycin-resistant phenotypes of group A beta-hemolytic streptococcus. 2000 Jan-Feb Chemotherapy pmid:10601794
Fluhr JW et al. In-vitro and in-vivo efficacy of zinc acetate against propionibacteria alone and in combination with erythromycin. 1999 Zentralbl. Bakteriol. pmid:10603662
Marre R and Trautmann M [Community-acquired respiratory tract infections. Current data on the efficacy of various classes of antibiotics and antibiotic resistance of the main prevalent bacteria species]. 1999 Med. Klin. (Munich) pmid:10603732
Ku YY et al. Synthesis and antibacterial activities of novel 12-O-methylerythromycin A derivatives. 1999 J. Antibiot. pmid:10604761
Ianaro A et al. Anti-inflammatory activity of macrolide antibiotics. 2000 J. Pharmacol. Exp. Ther. pmid:10604943
Sato Y et al. Adjuvant effect of a 14-member macrolide antibiotic on DNA vaccine. 1999 Cell. Immunol. pmid:10607432
Wang JS et al. Fluvoxamine is a more potent inhibitor of lidocaine metabolism than ketoconazole and erythromycin in vitro. 1999 Pharmacol. Toxicol. pmid:10608481
Honein MA et al. Infantile hypertrophic pyloric stenosis after pertussis prophylaxis with erythromcyin: a case review and cohort study. 1999 Dec 18-25 Lancet pmid:10609814